NuVasive Announces $154.4M Revenue for 2Q, Up 16.1%

NuVasive, a medical device company focused on minimally disruptive surgical products and procedures for the spine, announced revenue of $154.4 million for the second quarter this year, up 16.1 percent from the same period in 2011.

Advertisement

The second quarter revenues also indicate a 1.8 percent increase over the $151.7 million reported for the first quarter 2012. Gross profit for the second quarter 2012 was $117.9 million and gross margin was 76.3 percent, compared to a gross profit of $107.5 million and a gross margin of 80.8 percent for the second quarter last year.

The company also reported higher operating expenses for the second quarter 2012 of $104.9 million compared to $96.0 million in the second quarter last year. The higher operating expenses stemmed from additional costs associated with higher revenue and infrastructure expansion.

More Articles on Orthopedic Devices:

Minimally Invasive Surgery Market to Reach $35.5B by 2016

MiMedx Revenues Reach $4.9M in 2Q, 153% Increase

China Device Market Expected Grew at 20.5% CAGR From 2006-2011

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.